Professional Documents
Culture Documents
SERO-NEGATIVE ARTHRITIS
Dr.Hussein Alemeamar
MBChB, MSc, MRCP(UK)
Topics
Rheumatoid Arthritis
spondyloarthropathies
RA - Prevalence
most common persistent inflammatory arthritis, occurring throughout the
world and in all ethnic groups
RA - Pathophysiology
complex interaction between genes and environment, leading to a
breakdown of immune tolerance and synovial inflammation in a
characteristic symmetric pattern
RA - Clinical Features
- pain
- Joint swelling
- Morning Stiffness
Symmetrical
sparing
of DIP
joints
RA - Clinical Features
Clinical course
5-10%
15%
75-80%
Rare
RA - Clinical Features
Muscle wasting
RA - Clinical Features
Ulnar deviation
RA - Clinical Features
Z chape thumb
RA - Clinical Features
Active
Inactive
VS
Morning stiffness
erythema
tenderness
high ESR &CRP
None of those Fx
only the deformity
RA - Clinical Features
RA - Clinical Features
RA - Clinical Features
Rheumatoid nodules
Rheumatoid nodules occur in up to 30% of patients, and are
found principally on the extensor surface of the forearm and
over pressure areas throughout the skin. Nodules are not
specific for RA but are useful in diagnosis and prognosis,
correlating with seropositivity, disease activity, and progression.
RA - Clinical Features
Scleritis
Episcleritis
VS
Painful
Painless
RA - Clinical Features
Association of splenomegaly and neutropenia in typically
rather destructive RA. Systemic disease, hepatomegaly,
and lymphadenopathy are also common, and the
occurrence of RA in relatives is higher than expected. In
uncomplicated cases, treatment should be conservative,
splenectomy remaining controversial and often only
transient in effect.
RA - Investigations
What is the Rheumatoid Factor (RF)?
Auto Ab, IgM against IgG (Ab against Ab)
If -ve --> can't rule out Rh A
If +ve--> Rh A and others (SLE, sys
sclerosis, infections ..etc) even in normal
people
Available
Must do in
all form of
arthritis
RA - Investigations
RA - Treatment
DMARDs
Corticosteroids
Biological
Others
RA - Treatment
RA - Rx:DMARDs
Methotrexate
RA - Treatment
Corticosteroids
SE
high dose of oral prednisolone initially (60 mg daily) and to reduce and stop this gradually
over a period of 3 months
low dose prednisolone (510 mg daily for 624 months)
intramuscular injections of methylprednisolone or triamcinolone every 68
weeks (also for flare up)
Intra articular corticosteroids are primarily indicated when there are one or two
problem joints with persistent synovitis despite good general control of the
disease
RA - Treatment
Biological
Costly
Against molecules regulating the immune response
UK recommendations are that biological therapy should be
initiated only in active RA (DAS28 > 5.1; p. 1100) when an
adequate trial of at least two other DMARDs (including
methotrexate) has failed
RA - Treatment
Anti-TNF- therapy
Common reactions include headache, nausea, and injectionsite reactions. Serious bacterial infections have been
reported, and patients with active infection should have their
treatment stopped. Patients at risk of recurrent infection
should not use these drugs (e.g. in-dwelling urinary catheter,
immunodeficiency states). Other reported side-effects
include demyelination, worsening of heart failure, lupus-like
syndromes, and bone marrow dyscrasias.
RA - Treatment
RA - Treatment
The spondyloarthropathies
The seronegative spondyloarthropathies are classically characterised by the
following:
Sacroiliitis & inflammatory back pain;
enthesitis.
There is a striking association with carriage of the HLA-B27 allele,
particularly for ankylosing spondylitis (> 95%) and reactive arthritis (90%),
These diseases may also be accompanied by:
asymmetric peripheral arthritis;
extra-articular disease;
anterior uveitis.
The group is made up of several conditions that often overlap. These are:
ankylosing spondylitis;
juvenile enthesitis-related arthritis;
psoriatic arthritis;
reactive arthropathy;
enteropathic arthritis;
undifferentiated spondylitis.
Ankylosing spondylitis
Ankylosing Spondylitis
radiological evidence: sacroilitis
AS - History
symptomatic sacroilitis (persistent back pain and
stiffness for > 3 months) associated with morning
stiffness and improvement on exercise or worsening with
rest
AS - Physical Examination
protuberant abdomen
severe kyphosis with ? posture
decreased cervical movement
decreased spinal movement
Increased occiput to wall distance
decreased chest expansion
Schober's test > assess spinal movement
AS - Dx criteria
AS - Systemic manifestations
7 "A's"
Atlanto-axial subluxation
Anterior uveitis
Apical lung fibrosis
Aortic incompetence
AV conduction defect
Amyloidosis
Achilles tendonitis
AS - Systemic manifestations
Anterior uveitis
AV block > pacemaker
Aortic regurgitation
AS - Systemic manifestations
apical fibrosis
Atlanto-axial subluxation
AS - Systemic manifestations
Achilles tendonitis
Amyloidosis
Is AS a genetic disease?
HLA-B27 Ag is present in 95% of Caucasian
patients with AS.
It is present in 8% of healthy adults.
The risk of transferring the HLA-B27 Ag to
offspring is 50% and these children have 1:3 risk
of developing the disease.
testing for HLA-B27 is unnecessary.
AS - Ix
Mainly radiological (X-ray, MRI)
Rh F > -ve, ANA > -ve
HLA-B27 (as discussed above)
Inflam markers (ESR & CRP) are only +ve in about 50% of
cases
AS - X-ray
Sacroilitis >inflammation of the sacroiliac joints
space
on X-ray
AS - X-ray
AS - MRI
Magnetic resonance imaging (MRI) is useful in
assessing early cartilage abnormalities and bone
marrow oedema.
Detect early disease before the patient
develop X-ray changes
AS - MRI
Twenty-one-year-old man with duration of AS 3 years; with lumbar IBP for 6 months.
Twenty-one-year-old man
with duration of AS 3 years.
(A) T2-FS: sagittal image of
lumbar spine, oedema of
spinous processes TX-TXITXII-LI-LII (long arrows) and
supraspinatus ligament
between TXI-LI (short arrow)
and Schmorls hernies. (B)
Axial T2-FS image. L1: bone
marrow oedema of spinous
process (arrow).
AS - Mx
Genetic counselling
PhysioRx
Occupational Rx
Analgesia
NSAIDs
Corticosteroids: only pulse i.v. steroids are
occasionally used, no role for oral steroids
DMARDs: methotrexate & sulphasalazine have
some effects on peripheral disease but not on
the spine
Biological Rx: anti-TNF alpha Rx adalimumab &
etanercept is approved by NICE to Rx AS
Arthritis
Enthesitis
Dactylitis
sausage-like swelling
of the finger or toe,
due to inflam. of
tendon sheet and soft
tissues.
PSA - Patterns
The 5 clinical patterns of psoriatic arthritis are:
distal, involving the distal interphalangeal joints (DIP);
asymmetric oligoarthritis;
symmetrical polyarthritis, indistinguishable from RA;
spondylarthropathy.
Arthritis mutilans is a classic but uncommon manifestation
of psoriatic arthritis. Bone resorption leads to collapse of the
soft tissue in the digits, creating telescoping fingers. This can
also be seen in severe RA.
PSA - Systemic
manifestations
Gout
Apical pulmonary fibrosis
Aortic regurgitation
Uveitis
PSA vs RhA
PSA - Rx
Patient education
PhysioRx
Occupational Rx
Analgesia
NSAIDs (in some patients NSAIDs may worsen the
psoriasis)
Corticosteroids: only intra-articular injection for single
troublesome joints. Avoid systemic steroids, since skin
disease may flare-up on steroids withdrawal.
DMARDs: methotrexate, sulphasalazine & cyclosporin are
effective on skin & peripheral disease but not on the spine
Biological Rx: anti-TNF alpha Rx infliximab, adalimumab
and etanercept is approved by NICE to Rx PSA (effective
for skin and joints)
Reactive arthropathy
Arthritis
Reactive arthropathy
Mucocutaneous features include painless circinate balanitis of
the glans penis, and pustular psoriasis of the palms or feet
(keratoderma blennorrhagica); these can be associated with a
more severe outcome.
Reactive arthropathy
Conjunctivitis is observed early. Uveitis is less frequent early in disease
Reactive arthropathy
Ix
Rx
There is no specific cure
NSAIDs and local corticosteroid injections are the mainstay of
therapeutic intervention
If symptoms persist longer than 6 months and there is clinical
evidence of ongoing synovitis and joint destruction then a diseasemodifying agent, such as sulfasalazine, MTX, or azathioprine, should
be considered.
Px
majority of patients are in complete remission at the end of 2 years,
most within 6 months
Enteric arthropathy
The arthropathies of ulcerative colitis and Crohn's disease have many
similarities, and the combination of peripheral and axial skeletal disease,
enthesopathies, mucocutaneous, and ocular disease fits neatly into the
diagnostic realm of the spondylarthropathies.
The exact pathology is unknown
Thank you